Results 301 to 310 of about 236,526 (353)

Ontogeny of drug-induced fatty liver disease (DIFLD): from key initiating events to disease phenotypes. [PDF]

Arch Toxicol
López-Pascual E, Moreno-Torres M, Moro E, Rapisarda A, Ortega-Vallbona R, Serrano-Candelas E, Gozalbes R, Jover R, Castell JV.   +8 more
europepmc   +1 more source

Plasticity of histone modification around Cidea and Cidec genes with secondary bile in the amelioration of developmentally-programmed hepatic steatosis

, 2019
Urmi Jeenat Ferdous, Yukiko Kohmura‐Kobayashi, Keiko Muramatsu‐Kato, Natsuyo Hariya, Divyanu Jain, Naoaki Tamura, Toshiyuki Uchida, Kazunao Suzuki, Yoshihiro Ogawa, Nobuaki Shiraki, Kazuki Mochizuki, Takeo Kubota, Naohiro Kanayama, Hiroaki Itoh   +13 more
openalex   +1 more source

The Proteomic Profiling of Circulating Extracellular Vesicles of Western Diet and Chemical‐Induced Murine MASH Model

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) is an increasingly prevalent chronic liver condition that can progress to severe complications such as metabolic dysfunction‐associated steatohepatitis (MASH). Despite its growing burden, there are no reliable non‐invasive biomarkers for tracking disease progression.
Szu‐Jen Wang, Yung‐Ho Wang, Jee‐Fu Huang, En‐Sheng Lin, Wei‐Shiun Chen, Chia‐Yang Li, Chia‐Yen Dai, Wan‐Long Chuang, Ming‐Lung Yu, Shu‐Chi Wang   +9 more
wiley   +1 more source

Correction: Probiotics attenuate valproate-induced liver steatosis and oxidative stress in mice. [PDF]

PLoS One
Song W, Yan X, Zhai Y, Ren J, Wu T, Guo H, Song Y, Li X, Guo Y.   +8 more
europepmc   +1 more source

Cashew Nut Oil Improves Lipid Metabolism and Fat Liver Deposition in High‐Fat Diet‐Fed C57BL/6J Mice

Lipids, EarlyView.
Thirty C57BL/6J mice were fed a high‐fat diet for 12 weeks to induce metabolic changes. They were then switched to diets containing cashew nut oil, soybean oil, or lard for another 12 weeks. Soybean oil reduced blood glucose, total cholesterol, LDL cholesterol, triglycerides, and liver steatosis.
Marcella Duarte Villas Mishima, Andressa Ladeira Bernardes, Carlos Alexandre Pinheiro, Luisa Gouveia Lana, Iasmim Xisto Campos, Valéria Silva de Lana, Izabela Maria Montezano de Carvalho, Patrícia Fontes Pinheiro, Renata Celi Lopes Toledo, Ana Paula Dionísio, Helen Hermana Hermsdorff, Maria do Carmo Gouveia Peluzio   +11 more
wiley   +1 more source

Endoscopic Bariatric Therapies for Metabolic Dysfunction-Associated Steatotic Liver Disease: Mechanistic Insights and Metabolic Implications. [PDF]

Biomedicines
Ghusn W, Sridharan M, Fromer R, Ozdemir M, Haff MG, Vargas EJ.   +5 more
europepmc   +1 more source

Effect of nano-curcumin supplementation on liver fibrosis in patients with NAFLD-associated fibrosis: a double-blind randomized controlled trial. [PDF]

Sci Rep
Gerami H, Mozaffari-Khosravi H, Mansour A, Sohrabpour AA, Poustchi H, Hashemi Taheri AP, Jaafari MR, Jambarsang S, Khayyatzadeh SS.   +8 more
europepmc   +1 more source

Harnessing Gut Microbiome–Brain–Liver Crosstalk: Novel Therapeutic Strategies for Metabolic Dysfunction‐Associated Steatotic Liver Disease

Medicine Bulletin, EarlyView.
This review reveals the complex mechanisms by which the brain–gut–liver axis (particularly the gut microbiota and its metabolites) drives MASLD, highlighting the therapeutic value of using phages to target and eliminate pathogenic bacteria and their metabolic products.
Xingtao Zhao, Ruolan Li, Jingdong Zhao, Ruiqi Sun, Shuo Zhang, Qiong Pan, Hongyan Lu, Jin Chai   +7 more
wiley   +1 more source

Gut dysbiosis is linked to severe steatosis and enhances its diagnostic performance in MASLD. [PDF]

eGastroenterology
Borges-Canha M, Centelles-Lodeiro J, Leite AR, Chaves J, Lourenço IM, Von-Hafe M, Vale C, Martins D, Silva C, Ferreira AC, Falony G, Liberal R, Fragão-Marques M, Barros A, Miranda I, Leite-Moreira A, Pimentel-Nunes P, Vieira-Silva S, Neves JS.   +18 more
europepmc   +1 more source

Exploring Autophagy Inducing Molecules: Targeting Diverse Pathways in Alzheimer's Disease Management

Medicinal Research Reviews, EarlyView.
ABSTRACT Neurodegenerative disorders, including Alzheimer's disease (AD), impose a significant burden on society due to their progressive nature and the associated healthcare costs. Autophagy, a vital cellular degradation process, has emerged as a promising therapeutic target in these disorders.
Baljinder Singh, Shubham Mahajan, Sadikalmahdi Abdella, Rehan Khan, Sanjay Garg   +4 more
wiley   +1 more source